BioVie Stock (NASDAQ: BIVI) stock price, news, charts, stock research, profile.
Open | $2.76 |
Close | - |
Volume / Avg. | 13.23K / 101.67K |
Day Range | $2.76 - $2.89 |
52 Wk Range | 2.07 - 58.20 |
Market Cap | $17.31M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 4.1% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BioVie (NASDAQ:BIVI) through any online brokerage.
Other companies in BioVie’s space includes: NKGen Biotech (NASDAQ:NKGN), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and Monopar Therapeutics (NASDAQ:MNPR).
BioVie has a consensus price target of $10.80.
The stock price for BioVie (NASDAQ: BIVI) is $2.8 last updated September 23, 2024 at 9:28 AM EDT.
There are no upcoming dividends for BioVie.
BioVie’s Q1 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for BioVie.
BioVie is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.